AW
Anthony W. Opipari
DELAYED 1 MONTH
Interim Chief Medical Officer and Executive Vice President, Translational Medicine
Odyssey Therapeutics, Inc.
Filings
1
Companies
1
Latest
May 7, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Odyssey Therapeutics, Inc.
Anthony W. Opipari
Interim Chief Medical Officer and Executive Vice President, Translational Medicine
Option Exercise
—
541 sh
May 12 12:30 AM
May 11, 2026